Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
Hoofdauteurs: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2012
|
Gelijkaardige items
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
door: Kampoli, A, et al.
Gepubliceerd in: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
door: Briasoulis, A, et al.
Gepubliceerd in: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
door: Tousoulis, D, et al.
Gepubliceerd in: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
door: Gounari, P, et al.
Gepubliceerd in: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
door: Tousoulis, D, et al.
Gepubliceerd in: (2011)